Ischemic postconditioning can reduce myocardial injury following myocardial infarction.
A potential pharmacological agent is the anesthetic Sevoflurane. The investigators'
hypothesis is that sevoflurane during primary percutaneous coronary intervention (PCI) will
reduce infarct size.